Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 324

Sort by

Sort Order Select

Journal Articles

Optimal Use of Thai Sinlek Rice (IR) Provides the Nutraceutical Effect on Erythropoiesis in Rats

Pimpisid Koonyosying, PhD, Ben Flemming, BSc, Supachai Ekwattanakit, PhDMD, Vip Viprakasit, MD DPhil, Suthat Fucharoen, MD, Somdet Srichairatanakool, PhD

Blood (2019) 134 (Supplement_1): 4808.

https://doi.org/10.1182/blood-2019-129679

Published: 2019

Journal Articles

Aberrant Responsiveness of Erythropoiesis to Iron Deficiency in Polycythemia Vera

Maria Feola, PhD, Daniel Moskop, Nada Terra, Young C. Park, Andrew Dunbar, MD, Ross L. Levine, MD, Ronald Hoffman, MD, Yelena Ginzburg, MD

Blood (2019) 134 (Supplement_1): 429.

https://doi.org/10.1182/blood-2019-131095

Published: 2019

Journal Articles

Hepcidin-Mediated Ferroportin Control in the Bone Marrow Is Dispensable

Katja Muedder, Bonadonna Michael, Bruno Galy, PhD, Martina U. Muckenthaler, PhD, Sandro Altamura, PhD

Blood (2019) 134 (Supplement_1): 3531.

https://doi.org/10.1182/blood-2019-126655

Published: 2019

Journal Articles

Generation and Characterisation of KY1066, a Fully Human Antibody Targeting the Enzymatic Activity of Matriptase-2 for the Treatment of Iron Overload in Beta Thalassemia

Matthew Wake, PhD, Jonathan Papworth, BSc, Luke Bayliss, BSc, Benjamin Grimshaw, PhD, Natalie Rynkiewicz, PhD, Jemima Paterson, BSc, Alicia Poindron, MSc, Erin Spearing, Emily Carter, Robyne Hudson, BSc, Verena Petzer, MD, Amelie Largounez, BSc, Audrey Belot, BSc, Anais Palin, BSc, Igor Theurl, MD PhD, Volker Germaschewski, Delphine Meynard, PhD

Blood (2019) 134 (Supplement_1): 3532.

https://doi.org/10.1182/blood-2019-124075

Published: 2019

Journal Articles

Efficacy and Safety of Ferric Carboxymaltose Injection in Reducing Anemia in Patients Receiving Chemotherapy for Non-Myeloid Malignancies: A Phase 3, Placebo-Controlled Study (IRON CLAD)

Jeffrey A. Gilreath, PharmD, Tamta Makharadze, MD, Ralph V. Boccia, MD, Anna Krupa, PharmD, David H. Henry, MD

Blood (2019) 134 (Supplement_1): 3535.

https://doi.org/10.1182/blood-2019-132135

Published: 2019

Journal Articles

Safety and Efficacy of 1020 Mg Total Dose Infusion of Ferumoxytol in a Veterans Health System

Paige May, PharmD, Preetika Pai, PharmD, Katherine Boles, PharmD, BCPS, Ashley McGee, PharmD, MBA, BCOP, Jess David Delaune, MD, Tanaka Dang, BS, Jessica M. Schmit, MD

Blood (2019) 134 (Supplement_1): 3538.

https://doi.org/10.1182/blood-2019-130709

Published: 2019

Journal Articles

Evaluating the Volumetric Liver Fat Fraction in Patients Referred for Investigation of Hyperferritinemia

Aoife Dervin, MBBS, BSc, MRCP, Perla Eleftheriou, FRCPath, MRCP, Deepak Suri, MBBS FRCP, Sara Trompeter, MBChB BSc MRCPCH FRCPath MSc, Maciej W Garbowski, MD PhD, Tim St. Pierre, John B. Porter, MA MDFRCP FRCPath, Emma Drasar, MBBS MRCP FRCPath PhD

Blood (2019) 134 (Supplement_1): 3539.

https://doi.org/10.1182/blood-2019-128122

Published: 2019

Journal Articles

Regulation of Iron Homeostasis By PTG-300 Improves Disease Parameters in Mouse Models for Beta-Thalassemia and Hereditary Hemochromatosis

Roopa Taranath, PhD, Gregory Bourne, PhD, Li Zhao, MD PhD, Brian Frederick, MS, Chelsea King, BA, David Liu, PhD

Blood (2019) 134 (Supplement_1): 3540.

https://doi.org/10.1182/blood-2019-129309

Published: 2019

Journal Articles

Hepcidin, Soluble Transferrin Receptor, and Other Biomarkers of Iron Status Distributions in Healthy 2 Years Old Infants from a National Ambulatory Study in France

Anne-Sylvia Sacri, MD PhD, Thibaud Lefebvre, Pharm D.,PhD, Mariane De Montalembert, MD, Alain Bocquet, MD, Piotr Gembara, MD, Brigitte Pinçant, MD, Serge Hercberg, MD, PhD, Corinne Levy, MD, Amandine Ganon, Pharm D., Laurent Gouya, MD, PhD, Martin Chalumeau, MD, PhD

Blood (2019) 134 (Supplement_1): 4809.

https://doi.org/10.1182/blood-2019-128982

Published: 2019

Journal Articles

Normal Hemoglobin Concentrations in Obstructive Sleep Apnea and Associated Neocytolysis-Mediated Hemolysis and Inflammation Mediated Suppression of Expected Elevated Hemoglobin

Jihyun Song, PhD, Krishna M Sundar, MD, Monika Horvathova, MSc, PhD, Tsewang Tashi, MD, Carsten Lundby, PhD, Tomas Ganz, MD PhD, Josef T. Prchal, MD

Blood (2019) 134 (Supplement_1): 3507.

https://doi.org/10.1182/blood-2019-131269

Published: 2019

Journal Articles

Correction of Iron Deficiency in Hospitalized Heart Failure Patients Does Not Improve Patient Outcomes

Ronak Mistry, DO, Andrew Kohut, MD MPH, Patricia Locantore-Ford, MD

Blood (2019) 134 (Supplement_1): 4812.

https://doi.org/10.1182/blood-2019-123568

Published: 2019

Journal Articles

Effect of Oral Iron Treatment in Tmprss6 Knock-out Mouse Model

Elisa Brilli, PhD, Michela Asperti, PhD, Annalisa Castagna, B.S., PhD, Claudio Cerchione, MD PhD, Domenico Girelli, MD, PhD, Maura Poli, PhD, Germano Tarantino

Blood (2019) 134 (Supplement_1): 2235.

https://doi.org/10.1182/blood-2019-122416

Published: 2019

Journal Articles

Altered Iron Parameters and Hepcidin Levels in a General Population: Lessons from the CHRIS Study

Fabiana Busti, MD PhD, Annalisa Castagna, B.S., PhD, Giacomo Marchi, MD, Oliviero Olivieri, MD, Peter Pramstaller, MD, Domenico Girelli, MD, PhD

Blood (2019) 134 (Supplement_1): 2239.

https://doi.org/10.1182/blood-2019-127098

Published: 2019

Journal Articles

Diagnosing Absolute Iron-Deficiency Anemia in Patients on Hemodialysis in a Tertiary Care Centre: A Retrospective Chart Review

Robert C. Clayden, MSc, MD, Wilma Hopman, MSc, Frances Macleod, RN, David Good, MD FRCPC, Jocelyn Garland, MD FRCPC, Lawrence Hookey, MD FRCPC, Annette E. Hay

Blood (2019) 134 (Supplement_1): 4814.

https://doi.org/10.1182/blood-2019-129197

Published: 2019

Journal Articles

Erythropoietin Is Associated with a Decline in the iFGF23/cFGF23 Ratio in Patients with Various Hereditary Hemolytic Anemias

Annelies J. Van Vuren, MD, Michele F. Eisenga, MD PhD, Stephanie van Straaten, MD PhD, Andreas Glenthøj, MD PhD, Carlo A.J.M. Gaillard, MD PhD, Stephan J.L. Bakker, MD PhD, Martin H. de Borst, MD PhD, Richard van Wijk, PhD, Eduard J. van Beers, MD PhD

Blood (2019) 134 (Supplement_1): 4793.

https://doi.org/10.1182/blood-2019-124074

Published: 2019

Journal Articles

Targeting the BMP Receptor Inhibitor FKBP12 to Upregulate Hepcidin in Wild-Type and Hemojuvelin-Hemochromatosis Models

Mariateresa Pettinato, Mariam Aghajan, PhD, Violante Olivari, MSc, Alessandro Dulja, MSc, Antonella Nai, PhD, Jessica Bordini, PhD, Alessandro Campanella, PhD, Alessia Pagani, PhD, Shuling Guo, PhD, Clara Camaschella, MD, Laura Silvestri, PhD

Blood (2019) 134 (Supplement_1): 955.

https://doi.org/10.1182/blood-2019-126496

Published: 2019

Journal Articles

A Multicenter, Italian Trial of Early Iron Chelation Therapy with Low Dose Deferasirox (Exjade®) in Patients with Low/Intermediate-1 Risk MDS at the Beginning of Transfusional Story

Emanuele Angelucci, MD, Mario Capasso, PhD, Matteo Giovanni Della Porta, MD, Gian Luca Forni, Domenico Girelli, MD, PhD, Esther Natalie Oliva, MD, Federica Pilo, MD, Marino Clavio, MD, Marta Riva, MD, Annamaria Pelizzari, MD, Pasquale Niscola, MD PhD, Daniela Cilloni, MD PhD, Gianni Binotto, MD, Elena Crisà, MD, Valeria Santini, MD

Blood (2019) 134 (Supplement_1): 4256.

https://doi.org/10.1182/blood-2019-125575

Published: 2019

Journal Articles

Iron Deficiency Anemia Caused By Malabsorption from Proton Pump Inhibition

Michael Boxer, MD

Blood (2019) 134 (Supplement_1): 962.

https://doi.org/10.1182/blood-2019-122154

Published: 2019

Journal Articles

Transfusion-Induced Impairment of Macrophage Responses Is Partially Restored By the Iron Chelator Deferasirox

Francesca Vinchi, PhD, Richard Sparla, Sara Passos, PhD, Heike Weidner, Martina Rauner, PhD, Uwe Platzbecker, Martina U. Muckenthaler, PhD

Blood (2018) 132 (Supplement 1): 3625.

https://doi.org/10.1182/blood-2018-99-113016

Published: 2018

Journal Articles

Hepatocyte Iron Content Controls BMP6-Dependent Hepcidin Regulation

Sandro Altamura, PhD, Silvia Colucci, MSc, Julia Schmidt, Katja Muedder, Joana Neves, Matthias Hentze, Prof., Martina U. Muckenthaler, PhD

Blood (2018) 132 (Supplement 1): 3626.

https://doi.org/10.1182/blood-2018-99-116109

Published: 2018

NARROW

Optimal Use of Thai Sinlek Rice (IR) Provides the Nutraceutical Effect on Erythropoiesis in Rats

Aberrant Responsiveness of Erythropoiesis to Iron Deficiency in Polycythemia Vera

Hepcidin-Mediated Ferroportin Control in the Bone Marrow Is Dispensable

Generation and Characterisation of KY1066, a Fully Human Antibody Targeting the Enzymatic Activity of Matriptase-2 for the Treatment of Iron Overload in Beta Thalassemia

Efficacy and Safety of Ferric Carboxymaltose Injection in Reducing Anemia in Patients Receiving Chemotherapy for Non-Myeloid Malignancies: A Phase 3, Placebo-Controlled Study (IRON CLAD)

Safety and Efficacy of 1020 Mg Total Dose Infusion of Ferumoxytol in a Veterans Health System

Evaluating the Volumetric Liver Fat Fraction in Patients Referred for Investigation of Hyperferritinemia

Regulation of Iron Homeostasis By PTG-300 Improves Disease Parameters in Mouse Models for Beta-Thalassemia and Hereditary Hemochromatosis

Hepcidin, Soluble Transferrin Receptor, and Other Biomarkers of Iron Status Distributions in Healthy 2 Years Old Infants from a National Ambulatory Study in France

Normal Hemoglobin Concentrations in Obstructive Sleep Apnea and Associated Neocytolysis-Mediated Hemolysis and Inflammation Mediated Suppression of Expected Elevated Hemoglobin

Correction of Iron Deficiency in Hospitalized Heart Failure Patients Does Not Improve Patient Outcomes

Effect of Oral Iron Treatment in Tmprss6 Knock-out Mouse Model

Altered Iron Parameters and Hepcidin Levels in a General Population: Lessons from the CHRIS Study

Diagnosing Absolute Iron-Deficiency Anemia in Patients on Hemodialysis in a Tertiary Care Centre: A Retrospective Chart Review

Erythropoietin Is Associated with a Decline in the iFGF23/cFGF23 Ratio in Patients with Various Hereditary Hemolytic Anemias

Targeting the BMP Receptor Inhibitor FKBP12 to Upregulate Hepcidin in Wild-Type and Hemojuvelin-Hemochromatosis Models

A Multicenter, Italian Trial of Early Iron Chelation Therapy with Low Dose Deferasirox (Exjade®) in Patients with Low/Intermediate-1 Risk MDS at the Beginning of Transfusional Story

Iron Deficiency Anemia Caused By Malabsorption from Proton Pump Inhibition

Transfusion-Induced Impairment of Macrophage Responses Is Partially Restored By the Iron Chelator Deferasirox

Hepatocyte Iron Content Controls BMP6-Dependent Hepcidin Regulation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only